Cargando…
Calcineurin inhibitors in the treatment of primary focal segmental glomerulosclerosis: A protocol of systematic review and meta-analysis of randomized controlled trials
BACKGROUND: Evidence suggesting a role for including calcineurin inhibitors(CNIs) in early therapy remains limited for low quality and mainly based on small observation cohort study. We will conduct a systematic reviews to explore the effect and adverse effect of calcineurin inhibitors compared with...
Autores principales: | Xue, Guozhong, Wang, Xinbin, Li, Shuwen, Dai, Enlai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850689/ https://www.ncbi.nlm.nih.gov/pubmed/33530282 http://dx.doi.org/10.1097/MD.0000000000024533 |
Ejemplares similares
-
Pembrolizumab-induced focal segmental glomerulosclerosis: A case report
por: Kim, Da Woon, et al.
Publicado: (2021) -
Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report
por: Choi, Sae Byeol, et al.
Publicado: (2021) -
Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study
por: Gu, Qiu-hua, et al.
Publicado: (2016) -
Comparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy: A protocol for systematic review and meta-analysis
por: Li, Kang, et al.
Publicado: (2022) -
Effect of cyclosporine A on focal segmental glomerulosclerosis caused by MYO1E mutation in a Chinese adult patient: A case report
por: Li, Ruizhao, et al.
Publicado: (2023)